FINWIRES · TerminalLIVE
FINWIRES

$EHC

9 stories mentioning EHCUpdated 23d ago

Every FINWIRES story that references EHC, newest first.

What are analysts saying about EHC?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on EHC?

Insider Trading

Encompass Health Insider Sold Shares Worth $630,166, According to a Recent SEC Filing

Andrew L Price, Chief Accounting Officer, on August 31, 2026, sold 5,211 shares in Encompass Health (EHC) for $630,166. Following the Form 4 filing with the SEC, Price has control over a total of 69,483 common shares of the company, with 69,483 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000209/xslF345X05/wk-form4_1788279701.xmlPrice: $121.99, Change: $+1.78, Percent Change: +1.48%

$EHC
Insider Trading

Encompass Health Insider Sold Shares Worth $1,121,711, According to a Recent SEC Filing

John Patrick Darby, Executive Vice President, General Counsel & Secretary, on August 10, 2026, sold 8,906 shares in Encompass Health (EHC) for $1,121,711. Following the Form 4 filing with the SEC, Darby has control over a total of 75,041 common shares of the company, with 75,041 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000190/xslF345X05/wk-form4_1786474028.xmlPrice: $125.03, Change: $-0.78, Percent Change: -0.62%

$EHC
Insider Trading

Encompass Health Insider Sold Shares Worth $21,724,095, According to a Recent SEC Filing

Mark J Tarr, Director, President & CEO, on August 10, 2026, sold 173,148 shares in Encompass Health (EHC) for $21,724,095. Following the Form 4 filing with the SEC, Tarr has control over a total of 267,814 common shares of the company, with 267,814 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000191/xslF345X05/wk-form4_1786474034.xmlPrice: $125.17, Change: $-0.64, Percent Change: -0.51%

$EHC
Insider Trading

Encompass Health Insider Sold Shares Worth $2,365,795, According to a Recent SEC Filing

Douglas E Coltharp, Executive Vice President & Chief Financial Officer, on August 10, 2026, sold 18,869 shares in Encompass Health (EHC) for $2,365,795. Following the Form 4 filing with the SEC, Coltharp has control over a total of 241,368 common shares of the company, with 50,508 shares held directly and 190,860 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000192/xslF345X05/wk-form4_1786474039.xmlPrice: $125.28, Change: $-0.53, Percent Change: -0.43%

$EHC
Wire

UBS Adjusts Price Target on Encompass Health to $155 From $150, Maintains Buy Rating

Encompass Health (EHC) has an average rating of buy and mean price target of $146.50, according to analysts polled by FactSet.Price: $124.99, Change: $+0.17, Percent Change: +0.14%

$EHC
Wire

Update: Encompass Health Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

(Updates with share moves in eighth paragraph).Encompass Health (EHC) reported Q2 adjusted earnings late Wednesday of $1.55 per diluted share, up from $1.40 a year earlier.Analysts polled by FactSet expected $1.48.Revenue for the three months ended June 30 was $1.60 billion, up from $1.46 billion a year earlier.Analysts expected $1.57 billion.For full-year 2026, the company now expects adjusted EPS of $6.02 to $6.25 on revenue of $6.41 billion to $6.49 billion, up from its prior guidance for adjusted EPS of $5.89 to $6.11 on revenue of $6.38 billion to $6.47 billion.Analysts expect $6.00 and $6.42 billion, respectively.Also, the company said its board has approved an increase in the aggregate common stock repurchase authorization to $1 billion.Shares rose nearly 13% in Thursday afternoon trading.Price: $125.27, Change: $+14.37, Percent Change: +12.96%

$EHC
Wire

Encompass Health Raises Quarterly Dividend by $0.02 to $0.21 a Share; Payable Oct. 15 to Holders of Record Oct. 1

Encompass Health Raises Quarterly Dividend by $0.02 to $0.21 a Share; Payable Oct. 15 to Holders of Record Oct. 1

$EHC
Research

TD Cowen Initiates Encompass Health at Buy With $125 Price Target

Encompass Health (EHC) has an average rating of buy and mean price target of $140.50, according to analysts polled by FactSet.

$EHC
Insider Trading

Encompass Health Insider Sold Shares Worth $2,958,550, According to a Recent SEC Filing

Douglas E Coltharp, Executive Vice President & Chief Financial Officer, on May 15, 2026, sold 27,694 shares in Encompass Health (EHC) for $2,958,550. Following the Form 4 filing with the SEC, Coltharp has control over a total of 260,237 common shares of the company, with 69,377 shares held directly and 190,860 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/785161/000078516126000158/xslF345X05/form4.xmlPrice: $106.89, Change: $+0.25, Percent Change: +0.23%

$EHC

Track with the FINWIRES app suite

FolioX
FolioX
Track EHC in your portfolio
WheelAI
WheelAI
Analyze EHC options with the wheel strategy
StockInsider
StockInsider
See market sentiment on EHC